Resources from the same session
TAX-TORC: An investigator initiated phase I study combining the dual mTORC1/2 inhibitor AZD2014 in combination with weekly paclitaxel in high-grade serous ovarian cancer
Presenter: Udai Banerji
Session: Developmental therapeutics
Resources:
Abstract
Phase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
Presenter: Markus Joerger
Session: Developmental therapeutics
Resources:
Abstract
Phase 1b study of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (PC)
Presenter: Colin Weekes
Session: Developmental therapeutics
Resources:
Abstract
Molecular imaging of PgP/BCRP inhibition at the blood brain barrier using elacridar and [11C]erlotinib PET
Presenter: Remy Verheijen
Session: Developmental therapeutics
Resources:
Abstract
Invited discussant abstracts 364PD and 365PD
Presenter: Christian Blank
Session: Developmental therapeutics
Resources:
Slides
Webcast
Invited discussant abstracts 361PD, 362PD and 363PD
Presenter: Irene Braña
Session: Developmental therapeutics
Resources:
Slides
Webcast
Invited discussant abstracts 357O and 358O
Presenter: Christophe Massard
Session: Developmental therapeutics
Resources:
Slides
Webcast
Interim results from the completed first-in-human phase I dose escalation study evaluating MP0250, a multi-DARPin® blocking HGF and VEGF, in patients with advanced solid tumors
Presenter: Mark Middleton
Session: Developmental therapeutics
Resources:
Abstract
First-in-human study of AC0010, a novel irreversible, mutant-selective EGFR inhibitor in patients with 1st generation EGFR TKI-resistant non-small cell lung cancer (NSCLC)
Presenter: Li Zhang
Session: Developmental therapeutics
Resources:
Abstract
Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
Presenter: Aung Naing
Session: Developmental therapeutics
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.